Amphastar Pharmaceuticals Inc (AMPH) Live Share Price, Invest From India

Amphastar Pharmaceuticals Inc Stock Performance

as on January 31, 2026 at 2:29 am IST

Day's Low
Day's High
$26.04
Day's Price Range
$26.60
$26.50
1.74%
Downside
0.38%
Upside
52 Week's Low
52 Week's High
$20.39
52-Week Price Range
$36.35
$26.50
23.08%
Downside
37.17%
Upside

Amphastar Pharmaceuticals Inc share price movements today

Previous Close: $26.15
Open: $26.15
Volume: 355.0K
Day's Low - High: $26.04 - $26.60
52 Week Low - High: $20.39 - $36.35

Amphastar Pharmaceuticals Inc Historical Returns

1 Month Return: -1.08 %
3 Month Return: + 3.88 %
1 Year Return: -24.03 %
3 Year Return: -12.46 %
5 Year Return: + 45.71 %

Amphastar Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Amphastar Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.2B

EPS (TTM)

3.3776

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.53%

PE Ratio (TTM)

11.77

Industry PE ratio

7.977787610619469

PEG Ratio

2.77

EBITDA

228.8M

Revenue (TTM)

723.3M

Profit Margin

15.43%

Return On Equity TTM

14.84%

Amphastar Pharmaceuticals Inc Stock Valuation

Track how Amphastar Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.

Amphastar Pharmaceuticals Inc in the last 5 years

Overview
Trends

Lowest (7.15x)

June 30, 2025

Industry (7.98x)

January 31, 2026

Today (11.77x)

January 31, 2026

Highest (25.13x)

March 31, 2021

LowHigh

Today’s Price to Earnings Ratio: 11.77x

Amphastar Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Amphastar Pharmaceuticals Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Amphastar Pharmaceuticals Inc	BUY	$1.2B	45.71%	11.77	15.43%
Regencell Bioscience Holdings Ltd	NA	$14.4B	NA	NA	0.00%
United Therapeutics Corporation	BUY	$21.6B	NA	18.08	40.65%
Haleon Plc Spon Ads	BUY	$46.2B	NA	22.54	13.81%
Viatris Inc.	HOLD	$15.2B	-22.95%	-21.95	-26.13%

See all

Stock Returns calculator for Amphastar Pharmaceuticals Inc Stock including INR - Dollar returns

The Amphastar Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Amphastar Pharmaceuticals Inc investment value today

Current value as on today

₹81,367

Returns

₹18,633

(-18.63%)

Returns from Amphastar Pharmaceuticals Inc Stock

₹24,003 (-24%)

Dollar Returns*

₹5,371 (+5.37%)

Analyst Recommendation on Amphastar Pharmaceuticals Inc Stock

Based on 12 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 12 analysts, 75% of analysts recommend a 'BUY' rating for Amphastar Pharmaceuticals Inc. Average target price of $31.57

Amphastar Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Amphastar Pharmaceuticals Inc.

What analysts predicted

16.06%UPSIDE

Target Price

$31.57

Current Price

$26.5

Analyzed by

12 Analysts

Target

$31.57

Amphastar Pharmaceuticals Inc target price $31.57, a slight upside of 16.06% compared to current price of $26.5. According to 12 analysts rating.

Amphastar Pharmaceuticals Inc Stock’s Investor Sentiment and Interest

Search interest for Amphastar Pharmaceuticals Inc Stock has increased by 260% in the last 30 days, reflecting an upward trend in search activity.

Time period: January 3, 2026 to February 2, 2026

Change:260% versus previous 30 day period

Amphastar Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	145	180	178	171	182	188	186	170	174	191
Gross Profit	72	108	96	87	95	101	86	85	86	98
Operating Income	36	72	53	48	55	57	45	37	42	25
EBITDA	43	90	64	61	72	68	65	52	61	41
Interest Expense	3	13	9	8	8	6	6	6	6	6
Depreciation	7	13	13	13	14	14	14	15	16	15
Income Before Tax	32	63	40	47	50	47	43	30	39	21
Income Tax Expense	6	14	4	4	12	7	5	5	8	4
Net Income	26	49	36	43	37	40	37	25	31	17
Net Profit Margin	17.93%	27.26%	20.31%	25.13%	20.81%	21.41%	20.35%	14.83%	17.79%	9.04%

Amphastar Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	251	255	240	294	322	349	437	498	644	731
Gross Profit	77	104	90	106	131	143	199	248	351	373
Operating Income	-6	15	0	-8	0	10	69	107	196	205
EBITDA	3	30	11	7	21	30	111	146	240	277
Interest Expense	0	1	0	0	0	0	0	1	27	30
Depreciation	-	-	15	16	21	25	26	28	35	57
Income Before Tax	-10	14	1	-9	60	4	83	114	169	189
Income Tax Expense	-7	4	-2	-3	13	3	20	23	31	29
Net Income	-2	10	4	-5	48	1	62	91	137	159
Net Profit Margin	-1.11%	4.13%	1.88%	-1.95%	15.18%	0.40%	14.19%	18.31%	21.34%	21.79%

Amphastar Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	49	36	43	37	40	37	25	31	17
Operating Cash Flow	64	23	55	69	59	29	35	35	52
Investing Cash Flow	-31	-103	15	-69	-34	-35	10	0	-19
Financing Cash Flow	86	-47	-13	-10	-22	-33	-14	-30	-4
Change in Cash	119	-126	56	-11	2	-40	31	4	28

Amphastar Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	10	4	-6	46	1	63	91	137	159
Operating Cash Flow	38	39	38	41	57	97	89	183	213
Investing Cash Flow	-39	-38	-42	-50	-36	-28	-32	-649	-124
Financing Cash Flow	7	-7	25	-3	-2	-37	-26	454	-80
Change in Cash	6	-6	20	-12	18	32	29	-11	7

Global Institutional Holdings in Amphastar Pharmaceuticals Inc

Funds	Holdings
Millennium Management LLC	1.33%
Charles Schwab Investment Management Inc	0.75%
BlackRock Inc	12.19%
Dimensional Fund Advisors, Inc.	3.5%
TD Global Investment Solutions – TD Epoch	2.67%

See all

Insights on Amphastar Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 170.52M → 191.84M (in $), with an average increase of 5.7% per quarter
POSITIVE IMPACT
Price Rise
In the last 6 months, AMPH stock has moved up by 24.9%
NO EFFECT
Against Peers
In the last 1 year, Regencell Bioscience Holdings Ltd has given 24890.0% return, outperforming this stock by 24914.0%
NO EFFECT
Against Peers
In the last 3 years, Regencell Bioscience Holdings Ltd has given 3108.4% return, outperforming this stock by 3123.4%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 31.03M → 17.35M (in $), with an average decrease of 44.1% per quarter

About Amphastar Pharmaceuticals Inc

amphastar pharmaceuticals, inc., headquartered in rancho cucamonga, california, established in 1996, is a recognized specialty pharmaceutical company that uses state-of-the-art, cgmp compliant facilities to develop, manufacture, and market injectable and inhalation products. in addition to the corporate headquarters, amphastar has five manufacturing facilities located in the united states, china and europe along with a state-of-the-art new drug research center. amphastar and its subsidiaries each have their own distinct focus that they skillfully bring together to meet the varied needs of the pharmaceutical industry. we currently produce approximately 15 injectable products while we continue to develop a portfolio of generic and branded products that target large markets with high technical barriers to entry. amphastar’s long-standing relationship with the major group purchasing organizations and drug wholesalers in the u.s. enables it to establish significant market share upon the int

Organisation	Amphastar Pharmaceuticals Inc
Headquarters	11570 6th Street, Rancho Cucamonga, CA, United States, 91730
Industry	Health Technology
CEO	Dr. Yongfeng Zhang Ph.D.
E-voting on shares	Click here to vote

Key Management of Amphastar Pharmaceuticals Inc

Name	Title
Dr. Ziping Luo Ph.D.	Chairman of the Board, Chief Scientist & COO
Dr. Yongfeng Zhang Ph.D.	Co-Founder, President, CEO, Chief Scientific Officer & Director
Mr. William J. Peters M.B.A.	CFO, Executive VP of Finance, Treasurer & Director
Mr. Jacob Liawatidewi M.B.A.	Executive VP of Sales, Marketing & Corporate Administration Center, Corporate Secretary and Director
Mr. Rong Zhou M.S.	Senior EVP of Production & EVP of Scientific Affairs
Mr. Dan Dischner M.B.A.	Senior Vice President of Human Resources & Corporate Communication
Tony Marrs M.B.A., M.P.H., M.S.	Executive VP of Regulatory Affairs & Clinical Operations

FAQs

What is Amphastar Pharmaceuticals Inc share price today?

Amphastar Pharmaceuticals Inc share price today is $26.5 as on January 31, 2026 at 2:29 am IST at the close of the market. Amphastar Pharmaceuticals Inc share today touched a day high of $26.6 and a low of $26.04.

What is the 52 week high and 52 week low for Amphastar Pharmaceuticals Inc share?

Amphastar Pharmaceuticals Inc share touched a 52 week high of $36.35 on January 31, 2025 and a 52 week low of $20.39 on August 1, 2025. Amphastar Pharmaceuticals Inc stock price today i.e. January 31, 2026 at 2:29 am IST is closed at $26.5,which is 27.10% down from its 52 week high and 30.00% up from its 52 week low.

What is Amphastar Pharmaceuticals Inc's market capitalisation today?

Amphastar Pharmaceuticals Inc market capitalisation is $0.00T as on January 31, 2026 at 2:29 am IST.

How to invest in Amphastar Pharmaceuticals Inc Stock (AMPH) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Amphastar Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Amphastar Pharmaceuticals Inc Shares that will get you 0.0566 shares as per Amphastar Pharmaceuticals Inc share price of $26.5 per share as on January 31, 2026 at 2:29 am IST.

What is the minimum amount required to buy Amphastar Pharmaceuticals Inc Stock (AMPH) from India?

Indian investors can start investing in Amphastar Pharmaceuticals Inc (AMPH) shares with as little as ₹91.641 or $1 (as of February 2, 2026 at 6:37 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹916.41 in Amphastar Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on February 2, 2026 at 6:37 am IST). Based on Amphastar Pharmaceuticals Inc share’s latest price of $26.5 as on January 31, 2026 at 2:29 am IST, you will get 0.3774 shares of Amphastar Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that Amphastar Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Amphastar Pharmaceuticals Inc stock has given 45.71% share price returns and 25.52% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?